Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): Identification of cannabinoid receptor subtype selective ligands

Journal of Pharmacology and Experimental Therapeutics

Volumn 278, Issue 3, 1996, Pages 989-999

  Showalter, Vincent M ^a   Compton, David R ^a   Martin, Billy R ^a   Abood, Mary E ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; ANANDAMIDE; CANNABINOID; CANNABINOID RECEPTOR AGONIST; CANNABINOL; RIMONABANT;

ANIMAL CELL; ARTICLE; CHO CELL; DRUG ABUSE; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; DRUG SPECIFICITY; HUMAN; HUMAN CELL; NERVOUS SYSTEM; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY;

ANIMALS; BINDING, COMPETITIVE; BRAIN; CANNABINOIDS; CELL MEMBRANE; CELLS, CULTURED; CHO CELLS; CRICETINAE; CYCLOHEXANOLS; GUANINE NUCLEOTIDES; HUMANS; LIGANDS; RATS; RECEPTOR, CANNABINOID, CB2; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; RECOMBINANT PROTEINS; SODIUM; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSFECTION;

EID: 0030425575     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. ADAMS, I. B., RYAN, W., SINGER, M., THOMAS, B. F., COMPTON, D. R., RAZDAN, R. K. AND MARTIN, B. R.: Evaluation of cannabinoid receptor binding and in vivo activities for anandamide analogs. J. Pharmacol. Exp. Ther. 273: 1172-1181, 1995.
2. BIDAUT-RUSSELL, M. AND HOWLETT, A. C.: Cannabinoid receptor-regulated cyclic AMP accumulation in the rat striatum. J. Neurochem. 57: 1769-1773, 1991.
3. BRADFORD, M. M.: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254, 1976.
4. CABRAL, G. A., TONEY, D. M., FISCHER-STENGER, K., HARRISON, M. P. AND MARCIANO-CABRAL, F.: Anandamide inhibits macrophage-mediated killing of tumor necrosis factor-sensitive cells. Life Sci. 56: 2065-2072, 1995.
5. CASY, A. F. AND PARFITT, R. T.: Opioid Analgesics: Chemistry and Receptors, Plenum Press, New York, 1986.
6. 8-THC analogs. Pharmacol. Biochem. Behav. 40: 509-512, 1991.
7. CHEN, C. AND OKAYAMA, H.: High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7: 2745-2752, 1987.
8. 50) on an enzymatic reaction. Biochem. Pharmacol. 22: 3099-3108, 1973.
9. CHILDERS, S. R., SEXTON, T. AND ROY, M. B.: Effects of anandamide on cannabinoid receptors in rat brain membranes. Biochem. Pharmacol. 47: 711-715, 1994.
10. CHILDERS, S. R. AND SNYDER, S. H.: Differential regulation by guanine nucleotides of opiate agonist and antagonist receptor interactions. J. Neuorchem. 34: 583-593, 1980.
11. 9-tetrahydrocannabinol-induced responses and apparent agonist activity. J. Pharmacol. Exp. Ther. 277: 586-594, 1996.
12. COMPTON, D. R., JOHNSON, M. R., MELVIN, L. S. AND MARTIN, B. R.: Pharmacological profile of a series of bicyclic cannabinoid analogs: Classification as cannabimimetic agents. J. Pharmacol. Exp. Ther. 260: 201-209, 1992.
13. COMPTON, D. R., RICE, K. C., DE COSTA, B. R., RAZDAN, R. K., MELVIN, L. S., JOHNSON, M. R. AND MARTIN, B. R.: Cannabinoid structure-activity relationships: Correlation of receptor binding and in vivo activities. J. Pharmacol. Exp. Ther. 265: 218-226, 1993.
14. DELEAN, A., MUNSON, P. J. AND RODBARD, D.: Simultaneous analysis of families of sigmoidal curves: Application to bioassay, radioligand assay, and physiological dose-response curves. Am. J. Physiol. 235: E97-E102, 1987.
15. DEUTSCH, D. G. AND CHIN, S. A.: Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist. Biochem. Pharmacol. 46: 791-796, 1993.
16. DEVANE, W. A., DYSARZ, I. F. A., JOHNSON, M. R., MELVIN, L. S. AND HOWLETT, A. C.: Determination and characterization of a cannabinoid receptor in rat brain. Mol. Pharmacol. 34: 605-613, 1988.
17. DEVANE, W. A., HANUS, L., BREUER, A., PERTWEE, R. G., STEVENSON, L. A., GRIFFIN, G., GIBSON, D., MANDELBAUM, A., ETINGER, A. AND MECHOULAM, R.: Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science (Wash. DC) 258: 1946-1949, 1992.
18. DEVANE, W. A., SPAIN, J. W., COSCIA, C. J. AND HOWLETT, A. C.: An assessment of the role of opioid receptors in the response to cannabimimetic drugs. J. Neurochem. 46: 1929-1935, 1986.
19. FACCI, L., TOSO, R. D., ROMANELLO, S., BURIANI, A., SKAPER, S. D. AND LEON, A.: Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc. Natl. Acad. Sci. U.S.A. 92: 3376-3380, 1995.
20. FELDER, C. C., BRILEY, E. M., AXELROD, J., SIMPSON, J. T., MACKIE, K. AND DEVANE, W. A.: Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction. Proc. Natl. Acad. Sci. U.S.A. 90: 7656-7660, 1993.
21. FELDER, C. C., VELUZ, J. S., WILLIAMS, H. L., BRILEY, E. M. AND MATSUDA, L. A.: Cannabinoid agonists stimulate both receptor- and nonreceptor-mediated signal transduction pathways in cells transfected with and expressing cannabinoid receptor clones. Mol. Pharmacol. 42: 838-845, 1992.
22. FRIDE, E. AND MECHOULAM, R.: Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent. Eur. J. Pharmacol 231: 313-314, 1993.
23. GAONI, Y. AND MECHOULAM, R.: Isolation, structure and partial synthesis of an active constituent of hashish. J. Am. Chem. Soc. 86: 1646-1647, 1964.
24. GÉRARD, C. M., MOLLEREAU, C., VASSART, G. AND PARMENTIER, M.: Molecular cloning of a human cannabinoid receptor which is also expressed in testis. Biochem. J. 279: 129-134, 1991.
25. HALL, J. M., CAULFIELD, M. P., WATSON, S. P. AND GUARD, S.: Receptor subtypes or species homologues: Relevance to drug discovery. Trends Pharmacol. 14: 376-383, 1993.
26. HOWLETT, A. C., BIDAUT-RUSSELL, M., DEVANE, W. A., MELVIN, L. S., JOHNSON, M. R. AND HERKENHAM, M.: The cannabinoid receptor: Biochemical, anatomical and behavioral characterization. Trends Neurosci. 13: 420-423, 1990.
27. i in the inhibition of adenylate cyclase by cannabimimetic drugs. Mol. Pharmacol. 29: 307-313, 1986.
28. HUFFMAN, J. W., DAI, D., MARTIN, B. R. AND COMPTON, D. R.: Design, synthesis and pharmacology of cannabimimetic indoles. Bioorgan. Med. Chem. Lett. 4: 563-566, 1994.
29. HULME, E. C. AND BIRDSALL, N. J. M.: Strategy and tactics in receptor-binding studies. In Receptor-Ligand Interactions: A Practical Approach, ed. by E. C. Hulme, pp. 63-176, Oxford University Press, New York, 1992.
30. KUSTER, J. E., STEVENSON, J. I., WARD, S. J., D'AMBRA, T. E. AND HAYCOCK, D. A.: Aminoalkylindole binding in rat cerebellum: Selective displacement by natural and synthetic cannabinoids. J. Pharmacol. Exp. Ther. 264: 1352-1363, 1993.
31. LAINTON, J. A. H., HUFFMAN, J. W., MARTIN, B. R. AND COMPTON, D. R.: 1-Alkyl-3-(1-naphthoyl)pyrroles: A new class of cannabinoid. Tetrahedron Lett. 36: 1401-1404, 1995.
32. 8-THC-dimethylheptyl in mice and dogs. Pharmacol. Biochem. Behav. 32: 661-666, 1989.
33. LYNN, A. B. AND HERKENHAM, M.: Localization of cannabinoid receptors and nonsaturable high-density cannabinoid binding sites in peripheral tissues of the rat: Implications for receptor-mediated immune modulation by cannabinoids. J. Pharmacol. Exp. Ther. 268: 1612-1623, 1994.
34. MACKIE, K., DEVANE, W. A. AND HILLE, B.: Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells. Mol. Pharmacol. 44: 498-503, 1993.
35. MATSUDA, L. A., LOLAIT, S. J., BROWNSTEIN, M. J., YOUNG, A. C. AND BONNER, T. I.: Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature (Lond.) 346: 561-564, 1990.
36. MUNRO, S., THOMAS, K. L. AND ABU-SHAAR, M.: Molecular characterization of a peripheral receptor for cannabinoids. Nature (Lond.) 365: 61-65, 1993.
37. MUNSON, A. E. AND FEHR, K. O.: Immunological effects of cannabis. In Adverse Health and Behavioral Consequences of Cannabis Use, ed. by K. O. Fehr and H. Kalant, pp. 257-353, Addiction Research Foundation, Toronto, 1983.
38. PACHECO, M. A., WARD, S. J. AND CHILDERS, S. R.: Differential requirements of sodium for coupling of cannabinoid receptors to adenylyl cyclase in rat brain membranes. J. Neurochem. 62: 1773-1782, 1994.
39. PERT, C. B. AND SNYDER, S. H.: Opiate receptor binding of agonists and antagonists affected differentially by sodium. Mol. Pharmacol. 10: 868-879, 1974.
40. RINALDI-CARMONA, M., BARTH, F., HÉAULME, M., SHIRE, D., CALANDRA, B., CONGY, C., MARTINEZ, S., MARUANI, J., NÉLIAT, G., CAPUT, D., FERRARA, P., SOUBRIÉ, P., BRELIÈRE, J. C. AND LE FUR, G.: SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett. 350: 240-244, 1994.
41. RODBELL, M., LIN, M. C., SALOMON, Y., LONDOS, C., HARWOOD, J. P., MARTIN, B. R., RENDELL, M. AND BERMAN, N.: Role of adenine and guanine nucleotides in the activity and response of adenylate cyclase systems. Adv. Cyclic Nucleotide Res. 5: 3-29, 1971.
42. ROSENTHAL, H. E.: A graphic method for the determination and presentation of binding parameters in a complex system. Anal. Biochem. 20: 525-532, 1967.
43. SCATCHARD, G.: The attractions of proteins for small molecules and ions. Ann. N.Y. Acad. Sci. 51: 660-672, 1951.
44. SMITH, P. B., COMPTON, D. R., WELCH, S. P., RAZDAN, R. K., MECHOULAM, R. AND MARTIN, B. R.: The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice. J. Pharmacol. Exp. Ther. 270: 219-227, 1994.
45. SPECTER, S., LANCZ, G. AND FRIEDMAN, H.: Marijuana and immunosuppression in man. In Drugs of Abuse and Immune Function, ed. by R. R. Watson, pp. 73-85, CRC Press, Boca Raton, 1990.
46. VOGEL, Z., BARG, J., LEVY, R., SAYA, D., HELDMAN, E. AND MECHOULAM, R.: Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase. J. Neurochem. 61: 353-355, 1993.
47. 9-THC-induced antinociception. J. Pharmacol. Exp. Ther. 273: 1235-1244, 1995.
48. ZIMMERMAN, A. M., TITISHOV, N., MECHOULAM, R. AND ZIMMERMAN, S.: Effect of stereospecific cannabinoids on the immune system. In Drugs of Abuse, Immunity and Immunodeficiency, ed. by H. Friedman, S. Spector, and T. W. Klein, pp. 71- 80, Plenum Press, New York, 1991.